Endocrinology, Vol 136, 3360-3368, Copyright © 1995 by Endocrine Society

ARTICLES

Differential expression of hepatic sterol carrier proteins in the streptozotocin-treated diabetic rat

MP McLean, JT Billheimer, KJ Warden and RB Irby
Department of Obstetrics and Gynecology, University of South Florida College of Medicine, Tampa 33606, USA.

Sterol carrier protein-2 (SCP2) is a 13.2-kilodalton protein that has been implicated in intracellular cholesterol transport, whereas a related sterol carrier protein, sterol carrier protein-X (SCPx; 58 kilodaltons) has been suggested to function also in the beta-oxidation of fatty acids. Although diabetes-related hyperlipidemia and altered cholesterol metabolism have been extensively studied, the intracellular cholesterol transport capacity during hyperglycemic states has not been examined. The fact that beta-oxidation is increased in diabetes whereas hepatic cholesterol metabolism is reduced suggests that differential expression of these sterol carrier proteins may accompany diabetic dyslipidemia. In this study, SCP2 protein levels were reduced by 60% in mildly hypercholesterolemic (cholesterol, > 130 and < 150 mg/dl; P < 0.01) diabetic rats and by 90% in severely hypercholesterolemic (cholesterol, > 150 mg/dl; P < 0.002) diabetic animals. In contrast, hepatic SCPx protein expression increased (3.5-fold) after diabetes induction with streptozotocin (STZ). The decline in SCP2 was inversely related to serum cholesterol levels. Hepatic SCP messenger RNA levels examined by ribonuclease protection assay demonstrated that hepatic SCP messenger RNA was increased 2-fold in diabetic animals. Northern blot analysis indicated that both the 0.8-kilobase SCP2-specific and the 2.1- kilobase SCPx-specific transcripts increased after STZ injection. SCPx protein induction preceded the decline in SCP2 by 4-5 days. Insulin treatment reversed the increase in SCPx and prevented the decline in SCP2. We conclude that SCP2 and SCPx are differentially expressed in the STZ-diabetic rat and suggest that this change in SCP expression should be considered a potential contributing mechanism through which cholesterol metabolism may be altered in diabetes.

This article has been cited by other articles:

				B. P. Atshaves, A. L. McIntosh, H. R. Payne, J. Mackie, A. B. Kier, and F. Schroeder Effect of branched-chain fatty acid on lipid dynamics in mice lacking liver fatty acid binding protein gene Am J Physiol Cell Physiol, March 1, 2005; 288(3): C543 - C558. [Abstract] [Full Text] [PDF]

				B. P. Atshaves, H. R. Payne, A. L. McIntosh, S. E. Tichy, D. Russell, A. B. Kier, and F. Schroeder Sexually dimorphic metabolism of branched-chain lipids in C57BL/6J mice J. Lipid Res., May 1, 2004; 45(5): 812 - 830. [Abstract] [Full Text] [PDF]

				O. Starodub, C. A. Jolly, B. P. Atshaves, J. B. Roths, E. J. Murphy, A. B. Kier, and F. Schroeder Sterol carrier protein-2 localization in endoplasmic reticulum and role in phospholipid formation Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1259 - C1269. [Abstract] [Full Text] [PDF]

				N. Stolowich, A. Frolov, A. D. Petrescu, A. I. Scott, J. T. Billheimer, and F. Schroeder Holo-sterol Carrier Protein-2. 13C NMR INVESTIGATION OF CHOLESTEROL AND FATTY ACID BINDING SITES J. Biol. Chem., December 10, 1999; 274(50): 35425 - 35433. [Abstract] [Full Text] [PDF]

				D. Lopez and M. P. McLean Sterol Regulatory Element-Binding Protein-1a Binds to cis Elements in the Promoter of the Rat High Density Lipoprotein Receptor SR-BI Gene Endocrinology, December 1, 1999; 140(12): 5669 - 5681. [Abstract] [Full Text]

				D. Lopez, T. W. Sandhoff, and M. P. McLean Steroidogenic Factor-1 Mediates Cyclic 3',5'-Adenosine Monophosphate Regulation of the High Density Lipoprotein Receptor Endocrinology, July 1, 1999; 140(7): 3034 - 3044. [Abstract] [Full Text]

				U. Seedorf, M. Raabe, P. Ellinghaus, F. Kannenberg, M. Fobker, T. Engel, S. Denis, F. Wouters, K. W.A. Wirtz, R. J.A. Wanders, et al. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function Genes & Dev., April 15, 1998; 12(8): 1189 - 1201. [Abstract] [Full Text]

				C. L. Baum, E. J. Reschly, A. K. Gayen, M. E. Groh, and K. Schadick Sterol Carrier Protein-2 Overexpression Enhances Sterol Cycling and Inhibits Cholesterol Ester Synthesis and High Density Lipoprotein Cholesterol Secretion J. Biol. Chem., March 7, 1997; 272(10): 6490 - 6498. [Abstract] [Full Text] [PDF]